The DOI matches its Crossref record; 69 of the 69 references it cites were found in a registry or an index.
C. elegans in high-throughput drug discovery
Open accessAbstract
C. elegans has proven to be a useful model organism for investigating molecular and cellular aspects of numerous human diseases. More recently, investigators have explored the use of this organism as a tool for drug discovery. Although earlier drug screens were labor-intensive and low in throughput, recent advances in high-throughput liquid workflows, imaging platforms and data analysis software have made C. elegans a viable option for automated high-throughput drug screens. This review will outline the evolution of C. elegans-based drug screening, discuss the inherent challenges of using C. elegans, and highlight recent technological advances that have paved the way for future drug screens.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
THE GENETICS OF CAENORHABDITIS ELEGANS
Brenner, S. (1974) · Genetics · doi:10.1093/genetics/77.1.71 · Cited by 15,081
Genome Sequence of the Nematode C. elegans : A Platform for Investigating Biology
The C. elegans Sequencing Consortium* (1998) · Science · doi:10.1126/science.282.5396.2012 · Cited by 4,485
A C. elegans mutant that lives twice as long as wild type
Kenyon, C., Chang, J., Gensch, E., Rudner, A., & Tabtiang, R. (1993) · Nature · doi:10.1038/366461a0 · Cited by 3,387
Kimura, K. D., Tissenbaum, H. A., Liu, Y., & Ruvkun, G. (1997) · Science · doi:10.1126/science.277.5328.942 · Cited by 2,245
Ogg, S., Paradis, S., Gottlieb, S., Patterson, G. I., Lee, L., Tissenbaum, H. A., & Ruvkun, G. (1997) · Nature · doi:10.1038/40194 · Cited by 1,932
Finding function in novel targets: C. elegans as a model organism
Kaletta, T., & Hengartner, M. O. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2031 · Cited by 1,093
Clausell-Tormos, J., Lieber, D., Baret, J.-C., El-Harrak, A., Miller, O. J., Frenz, L., Blouwolff, J., Humphry, K. J., Köster, S., Duan, H., et al. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.04.004 · Cited by 720
WormBase: a multi-species resource for nematode biology and genomics
Harris, T. W. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh066 · Cited by 715
Levitan, D., & Greenwald, I. (1995) · Nature · doi:10.1038/377351a0 · Cited by 705
Expression of human beta-amyloid peptide in transgenic Caenorhabditis elegans.
Link, C. D. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9368 · Cited by 687
Genes that regulate both development and longevity in Caenorhabditis elegans.
Larsen, P. L., Albert, P. S., & Riddle, D. L. (1995) · Genetics · doi:10.1093/genetics/139.4.1567 · Cited by 583
Lai, C.-H., Chou, C.-Y., Ch'ang, L.-Y., Liu, C.-S., & Lin, W.-C. (2000) · Genome Research · doi:10.1101/gr.10.5.703 · Cited by 472
High-throughput behavioral analysis in C. elegans
Swierczek, N. A., Giles, A. C., Rankin, C. H., & Kerr, R. A. (2011) · Nature Methods · doi:10.1038/nmeth.1625 · Cited by 456
Programmed cell death in Caenorhabditis elegans
Hengartner, M. O., & Robert Horvitz, H. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90076-f · Cited by 374
Assessment of normal and mutant human presenilin function in Caenorhabditis elegans
Levitan, D., Doyle, T. G., Brousseau, D., Lee, M. K., Thinakaran, G., Slunt, H. H., Sisodia, S. S., & Greenwald, I. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14940 · Cited by 358
A Central Role of the BK Potassium Channel in Behavioral Responses to Ethanol in C. elegans
Davies, A. G., Pierce-Shimomura, J. T., Kim, H., VanHoven, M. K., Thiele, T. R., Bonci, A., Bargmann, C. I., & McIntire, S. L. (2003) · Cell · doi:10.1016/s0092-8674(03)00979-6 · Cited by 357
Antifungal Chemical Compounds Identified Using a C. elegans Pathogenicity Assay
Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M., & Mylonakis, E. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030018 · Cited by 332
Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa
Darby, C., Cosma, C. L., Thomas, J. H., & Manoil, C. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15202 · Cited by 313
Identification of novel antimicrobials using a live-animal infection model
Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., & Ausubel, F. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604055103 · Cited by 294
High‐throughput screening and small animal models, where are we?
Giacomotto, J., & Ségalat, L. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.00725.x · Cited by 293
An antidepressant that extends lifespan in adult Caenorhabditis elegans
Petrascheck, M., Ye, X., & Buck, L. B. (2007) · Nature · doi:10.1038/nature05991 · Cited by 286
Ramot, D., Johnson, B. E., Berry, T. L., Carnell, L., & Goodman, M. B. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002208 · Cited by 278
A small-molecule screen in C. elegans yields a new calcium channel antagonist
Kwok, T. C. Y., Ricker, N., Fraser, R., Chan, A. W., Burns, A., Stanley, E. F., McCourt, P., Cutler, S. R., & Roy, P. J. (2006) · Nature · doi:10.1038/nature04657 · Cited by 274
The Caenorhabditis elegans Lifespan Machine
Stroustrup, N., Ulmschneider, B. E., Nash, Z. M., López-Moyado, I. F., Apfeld, J., & Fontana, W. (2013) · Nature Methods · doi:10.1038/nmeth.2475 · Cited by 257
McColl, G., Roberts, B. R., Pukala, T. L., Kenche, V. B., Roberts, C. M., Link, C. D., Ryan, T. M., Masters, C. L., Barnham, K. J., Bush, A. I., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-57 · Cited by 247
Stirman, J. N., Crane, M. M., Husson, S. J., Wabnig, S., Schultheis, C., Gottschalk, A., & Lu, H. (2011) · Nature Methods · doi:10.1038/nmeth.1555 · Cited by 216
Link, C. D. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.059 · Cited by 213
Genetics of RAS signaling in C. elegans
Sternberg, P. W., & Han, M. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01592-3 · Cited by 204
Anticonvulsant Medications Extend Worm Life-Span
Evason, K., Huang, C., Yamben, I., Covey, D. F., & Kornfeld, K. (2005) · Science · doi:10.1126/science.1105299 · Cited by 195
A predictive model for drug bioaccumulation and bioactivity in Caenorhabditis elegans
Burns, A. R., Wallace, I. M., Wildenhain, J., Tyers, M., Giaever, G., Bader, G. D., Nislow, C., Cutler, S. R., & Roy, P. J. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.380 · Cited by 186
Caenorhabditis elegans MPP+ Model of Parkinson’s Disease for High-Throughput Drug Screenings
Braungart, E., Gerlach, M., Riederer, P., Baumeister, R., & Hoener, M. C. (2004) · Neurodegenerative Diseases · doi:10.1159/000080983 · Cited by 186
An image analysis toolbox for high-throughput C. elegans assays
Wählby, C., Kamentsky, L., Liu, Z. H., Riklin-Raviv, T., Conery, A. L., O'Rourke, E. J., Sokolnicki, K. L., Visvikis, O., Ljosa, V., Irazoqui, J. E., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1984 · Cited by 181
Gosai, S. J., Kwak, J. H., Luke, C. J., Long, O. S., King, D. E., Kovatch, K. J., Johnston, P. A., Shun, T. Y., Lazo, J. S., Perlmutter, D. H., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015460 · Cited by 175
Self-citationKuwahara, T., Koyama, A., Koyama, S., Yoshina, S., Ren, C.-H., Kato, T., Mitani, S., & Iwatsubo, T. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn198 · Cited by 171
Artificial Dirt: Microfluidic Substrates for Nematode Neurobiology and Behavior
Lockery, S. R., Lawton, K. J., Doll, J. C., Faumont, S., Coulthard, S. M., Thiele, T. R., Chronis, N., McCormick, K. E., Goodman, M. B., & Pruitt, B. L. (2008) · Journal of Neurophysiology · doi:10.1152/jn.91327.2007 · Cited by 166
Smout, M. J., Kotze, A. C., McCarthy, J. S., & Loukas, A. C. (2010) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000885 · Cited by 165
Caenorhabditis elegans: A versatile platform for drug discovery
Artal‐Sanz, M., de Jong, L., & Tavernarakis, N. (2006) · Biotechnology Journal · doi:10.1002/biot.200600176 · Cited by 160
Analysis of nematode mechanics by piezoresistive displacement clamp
Park, S.-J., Goodman, M. B., & Pruitt, B. L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702138104 · Cited by 158
Enhanced Caenorhabditis elegans Locomotion in a Structured Microfluidic Environment
Park, S., Hwang, H., Nam, S.-W., Martinez, F., Austin, R. H., & Ryu, W. S. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002550 · Cited by 157
WormScan: A Technique for High-Throughput Phenotypic Analysis of Caenorhabditis elegans
Mathew, M. D., Mathew, N. D., & Ebert, P. R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033483 · Cited by 155
WormSizer: High-throughput Analysis of Nematode Size and Shape
Moore, B. T., Jordan, J. M., & Baugh, L. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057142 · Cited by 148
Analysis of Protein Domain Families inCaenorhabditis elegans
Sonnhammer, E. L. L., & Durbin, R. M. (1997) · Genomics · doi:10.1006/geno.1997.4989 · Cited by 142
Ben-Yakar, A., Chronis, N., & Lu, H. (2009) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2009.10.010 · Cited by 138
Pharmacology of delayed aging and extended lifespan of Caenorhabditis elegans
Collins, J. J., Evason, K. J., & Kornfeld, K. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.038 · Cited by 134
Lehner, B., Tischler, J., & Fraser, A. G. (2006) · Nature Protocols · doi:10.1038/nprot.2006.245 · Cited by 132
Presenilin is required for proper morphology and function of neurons in C. elegans
Wittenburg, N., Eimer, S., Lakowski, B., Röhrig, S., Rudolph, C., & Baumeister, R. (2000) · Nature · doi:10.1038/35018575 · Cited by 128
Sundaram, M. V., & Greenwald, I. (1993) · Genetics · doi:10.1093/genetics/135.3.765 · Cited by 124
Invertebrate Animal Models of Diseases as Screening Tools in Drug Discovery
Ségalat, L. (2007) · ACS Chemical Biology · doi:10.1021/cb700009m · Cited by 120
Gieseler, K., Grisoni, K., & Ségalat, L. (2000) · Current Biology · doi:10.1016/s0960-9822(00)00691-6 · Cited by 119
Rand, J. B., & Johnson, C. D. (1995) · Methods in cell biology · doi:10.1016/s0091-679x(08)61388-6 · Cited by 114
Drug Absorption Efficiency in Caenorhbditis elegans Delivered by Different Methods
Zheng, S., Ding, A.-J., Li, G., Wu, G.-S., & Luo, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056877 · Cited by 109
Signalling pathways initiated by receptor protein tyrosine kinases in Drosophila
Perrimon, N. (1994) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(94)90145-7 · Cited by 109
The ins and outs of programmed cell death during C. elegans development
Hengartner, M. O., & Horvitz, H. R. (1994) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1994.0100 · Cited by 104
Modeling Polyglutamine Pathogenesis in C. elegans
Brignull, H. R., Morley, J. F., Garcia, S. M. D. A., & Morimoto, R. I. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12016-9 · Cited by 103
Shi, W., Wen, H., Lu, Y., Shi, Y., Lin, B., & Qin, J. (2010) · Lab on a Chip · doi:10.1039/c0lc00256a · Cited by 95
Prednisone reduces muscle degeneration in dystrophin-deficient Caenorhabditis elegans
Gaud, A., Simon, J.-M., Witzel, T., Carre-Pierrat, M., Wermuth, C. G., & Ségalat, L. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.02.011 · Cited by 86
Perlmutter, D. H. (2006) · Autophagy · doi:10.4161/auto.2882 · Cited by 82
Self-citationNemo: a computational tool for analyzing nematode locomotion
Tsibidis, G. D., & Tavernarakis, N. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-86 · Cited by 79
The use of functional genomics in C. elegans for studying human development and disease
Kuwabara, P. E., & O’Neil, N. J. (2001) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1010306731764 · Cited by 77
Luo, L., Gabel, C. V., Ha, H.-I., Zhang, Y., & Samuel, A. D. T. (2008) · Journal of Neurophysiology · doi:10.1152/jn.00053.2008 · Cited by 77
SU-8 force sensing pillar arrays for biological measurements
Doll, J. C., Harjee, N., Klejwa, N., Kwon, R., Coulthard, S. M., Petzold, B., Goodman, M. B., & Pruitt, B. L. (2009) · Lab on a Chip · doi:10.1039/b818622g · Cited by 75
Leung, C. K., Wang, Y., Malany, S., Deonarine, A., Nguyen, K. H., Vasile, S., & Choe, K. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062166 · Cited by 75
OrthoDisease: A database of human disease orthologs
O'Brien, K. P., Westerlund, I., & Sonnhammer, E. L. L. (2004) · Human Mutation · doi:10.1002/humu.20068 · Cited by 64
A High‐Throughput Screen for Chemicals that Increase the Lifespan of Caenorhabditis elegans
Petrascheck, M., Ye, X., & Buck, L. B. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04377.x · Cited by 62
Disorders of Protein Misfolding: Alpha-1-Antitrypsin Deficiency as Prototype
Silverman, G. A., Pak, S. C., & Perlmutter, D. H. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.03.077 · Cited by 36
Self-citationIncreased lifespan in transgenic Caenorhabditis elegans overexpressing human α-synuclein
Vartiainen, S., Aarnio, V., Lakso, M., & Wong, G. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.05.005 · Cited by 29
Saur, T., DeMarco, S., Ortiz, A., Sliwoski, G. R., Hao, L., Wang, X., Cohen, B. M., & Buttner, E. A. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003313 · Cited by 29
Zheng, M., Gorelenkova, O., Yang, J., & Feng, Z. (2011) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2011.11.015 · Cited by 11
Cited by
Discovery and resupply of pharmacologically active plant-derived natural products: A review
Atanasov, A. G., Waltenberger, B., Pferschy-Wenzig, E.-M., Linder, T., Wawrosch, C., Uhrin, P., Temml, V., Wang, L., Schwaiger, S., Heiss, E. H., et al. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.08.001 · Cited by 2,904
AlSheikh, H. M. A., Sultan, I., Kumar, V., Rather, I. A., Al-Sheikh, H., Tasleem Jan, A., & Haq, Q. M. R. (2020) · Antibiotics · doi:10.3390/antibiotics9080480 · Cited by 295
C. elegans as a model organism for human mitochondrial associated disorders
Maglioni, S., & Ventura, N. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.02.003 · Cited by 54
Metadata
- Authors
- O'Reilly, L. P., Luke, C. J., Perlmutter, D. H., Silverman, G. A., & Pak, S. C.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2014-04
- Volume
- 69-70
- Pages
- 247-253
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2133130607
- Cited by
- 267
- References
- 69
- FWCI
- 1.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.